EFFICACY AND SAFETY OF VITAMIN-C FOR IRON ANEMIA PATIENTS

Introduction: Despite the increasing use of targeted therapies in cancer patients, chemotherapy remains a mainstay of cancer treatment.

Objectives: The main objective of the study is to analyse the efficacy and safety of Vitamin-C for iron anemia patients. Material and methods: This cross sectional study was conducted in Health department Punjab during 2019 to 2020. The data was collected from those patients who were suffering from iron deficiency anemia. Patients were treated for 3 months and assessed with a complete blood count every 2 weeks for 2 months; iron metabolism was measured at week 8.

Results: The data was collected from 100 female patients. The only factors which emerged as statistically significant from the adjusted logistic regression analysis model were insufficient intakes of iron (OR = 7.39; 95% CI: 1.45-37.57) and vitamin C (OR = 6.14; 95% CI: 1.34-28.27), frequent (≥2 times per week) tea consumption (OR = 0.01; 95% CI: 0.01-0.08), infrequent (≤2 times per week) red meat consumption (OR = 3.71; 95% CI: 1.01-13.61), and the possession of a personal history of IDA (OR = 6.00; 95% CI: 1.45-24.76).

Conclusion: It is concluded that taking oral iron alone was equivalent to taking oral iron supplemented with vitamin C in improving hemoglobin level and iron stores. Our results suggest that vitamin C is not essential for patients with IDA.